Clinical trial
Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1
NCT00218179 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00218179 |
|---|---|
| Title | Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1 |
| Official title | Prostate, Lung, Colon, and Ovarian Cancer (PLCO) Screen Trial |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Tobacco Use Disorder, Lung Cancer |
| Intervention type | Other |
| Interventions | Non-intervention |
| Enrollment | 200 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 23, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: